The LifeTime Ethics Stakeholder Workshop is just around the corner. Register now to secure your spot and attend the workshop on Wednesday, 10 July, at the Stem Cell Centre at Helmholtz Centre in Munich.

The workshop will try to identify the potential ethical, legal and societal issues (ELSI) raised by the development of the LifeTime technologies: single-cell, organoids and artificial intelligence. The workshop will address the need to align to guidelines and principles required by EU, international and national legislation.

The workshop will serve as a foundation to prepare a unified ethical framework for the whole consortium. The resulting framework will integrate ethics committee protocols for the procurement of patient samples and in vivo models, data management, use of digitalisation for data handling and AI integration.

The event brings together experts in the fields of scientific research, law and clinical studies to identify priority areas with ELSI challenges and to develop appropriate responses. The panelists at the LifeTime Ethics Stakeholder Workshop are:

  • Andrea Bondelli (Science Gallery International)
  • Sarion Bowers (Policy Office, Wellcome Sanger Institute, Cambridge)
  • Hervé Chneiweiss (International Bioethics Committee, UNESCO)
  • Costica Dumbrava (Policy Office, EU)
  • Angelika Eggert (Department of Pediatrics, Oncology and Hematology, Charité, Berlin)
  • Dominique Guellec (Science & Technology Policy Division, OECD)
  • Daniel Lahne (Legal Department, Helmholtz Centre Munich)
  • Dory Reiling (Retired senior judge in the Court of Amsterdam and in The Hague Court of Appeal, independent senior justice and IT expert)
  • Amedeo Santosuosso (Law, Science & New Technologies, University of Pavia)
  • Arnold Sauter (Technology Assessment, German Bundestag)
  • Ibo Van de Poel (Ethics and Technology, Delft University)  

Agenda of the event can be found here. Participation in the workshop is free of charge but registration is necessary. The deadline for registration is 26 June.

Categories: News

Leave a Reply

Your email address will not be published. Required fields are marked *

Twitter
LinkedIn
Facebook